Literature DB >> 33284083

System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.

Claire Snell-Rood1, Cathleen Willging2, David Showalter3, Hannah Peters1, Robin A Pollini4.   

Abstract

Background: Hub and spoke systems (HSS) are increasingly promoted as a systems-level intervention to expand access to medication for opioid use disorders (MOUD), particularly in rural areas with limited treatment options. The HSS model consists of sub-systems in which "hubs" deliver specialized expertise to a regional network of office-based opioid treatment (OBOT) providers in "spokes," who together create a continuum of acute and chronic care. Yet, little is known about system-level factors (e.g., system structure, financing) that influence HSS implementation and sustainability in rural areas.
Methods: For this case study, we conducted semi-structured interviews with substance use disorder treatment providers (N = 26) and system-level stakeholders (N = 16) in five rural HSS sub-systems throughout one state. We undertook iterative textual analysis of interview transcripts, identifying and coding themes related to key implementation constructs associated with the Exploration, Preparation, Implementation and Sustainability (EPIS) framework.
Results: California policy-makers adopted HSS to expand rural access to opioid treatment programs (OTPs, i.e., providers of methadone and other medications for opioid use disorder). However, stakeholders questioned the model's fit for rural regions featuring few established OTPs that could function as hubs and critiqued its treatment-focused approach, felt to sideline harm reduction service providers. Contracts to serve rural regions were awarded entirely to for-profit methadone providers, contributing to stigma and distrust among many buprenorphine providers whose organizations were later recruited as spokes. While hubs offered financial resources enabling some spokes to expand MOUD, the needs of spokes varied considerably. Relationships between hubs and spokes to facilitate the care continuum under HSS were restricted by limited behavioral health resources and the large distances characterizing rural California. Conclusions: This case study reveals how rural contextual factors such as geography and behavioral healthcare resource availability can dramatically influence differential HSS implementation.

Entities:  

Keywords:  Opioid use disorder; hub and spoke; implementation science; medication for opioid use disorder (MOUD); rural; system-level

Mesh:

Substances:

Year:  2020        PMID: 33284083     DOI: 10.1080/08897077.2020.1846149

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  5 in total

Review 1.  Scoping review of interventions to link individuals to substance use services at discharge from jail.

Authors:  Christine E Grella; Erika Ostlie; Dennis P Watson; Christy K Scott; John Carnevale; Michael L Dennis
Journal:  J Subst Abuse Treat       Date:  2022-01-04

2.  Barriers for Implementing the Hub and Spoke Model to Expand Medication for Opioid Use Disorder: A Case Study of Montana.

Authors:  Brandn Green; Danielle Christine Rhubart; Matthew R Filteau
Journal:  Subst Abuse       Date:  2021-08-30

3.  Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites.

Authors:  Dennis P Watson; Monte D Staton; Nicole Gastala
Journal:  Addict Sci Clin Pract       Date:  2022-07-28

4.  Association Between Interorganizational Collaboration in Opioid Response and Treatment Capacity for Opioid Use Disorder in Counties of Five States: A Cross-Sectional Study.

Authors:  William L Swann; Michael DiNardi; Terri L Schreiber
Journal:  Subst Abuse       Date:  2022-07-13

5.  It will end in tiers: A strategy to include "dabblers" in the buprenorphine workforce after the X-waiver.

Authors:  Brendan Saloner; Barbara Andraka Christou; Adam J Gordon; Bradley D Stein
Journal:  Subst Abus       Date:  2021-04-02       Impact factor: 3.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.